4.8 Review

Macrophage-Mediated Tissue Vascularization: Similarities and Differences Between Cornea and Skin

期刊

FRONTIERS IN IMMUNOLOGY
卷 12, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.667830

关键词

macrophages; monocytes; angiogenesis; cornea; skin; lymphangiogenesis

资金

  1. German Research Foundation (DFG) [FOR2240, Cu 47/4-2, Cu 47/6-1, Cu 47/9-1, Cu 47/12-2, HO 5556/1-2, EM 48/5-2, BO4489/1-1, BO4489/1-2, BO4489/3-1, FOR2599, 3927 49992]
  2. Center for Molecular Medicine Cologne
  3. EU COST [CA18116]
  4. CRC829 [73111208]
  5. CRC1403 [1403-414786233]
  6. Germany's Excellence Strategy -CECAD [EXC 2030 -390661388]

向作者/读者索取更多资源

Macrophages play a critical role in tissue vascularization in both health and disease contexts. Understanding the mechanisms of macrophage-mediated blood and lymphatic vessel growth in different tissues can provide insights into potential therapeutic interventions for various diseases.
Macrophages are critical mediators of tissue vascularization both in health and disease. In multiple tissues, macrophages have been identified as important regulators of both blood and lymphatic vessel growth, specifically following tissue injury and in pathological inflammatory responses. In development, macrophages have also been implicated in limiting vascular growth. Hence, macrophages provide an important therapeutic target to modulate tissue vascularization in the clinic. However, the molecular mechanisms how macrophages mediate tissue vascularization are still not entirely resolved. Furthermore, mechanisms might also vary among different tissues. Here we review the role of macrophages in tissue vascularization with a focus on their role in blood and lymphatic vessel formation in the barrier tissues cornea and skin. Comparing mechanisms of macrophage-mediated hem- and lymphangiogenesis in the angiogenically privileged cornea and the physiologically vascularized skin provides an opportunity to highlight similarities but also tissue-specific differences, and to understand how macrophage-mediated hem- and lymphangiogenesis can be exploited for the treatment of disease, including corneal wound healing after injury, graft rejection after corneal transplantation or pathological vascularization of the skin.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据